Harpagoside Inhibits RANKL-Induced Osteoclastogenesis via Syk-Btk-PLCγ2-Ca2+ Signaling Pathway and Prevents Inflammation-Mediated Bone Loss-Reference-Cited by-同舟云学术

Harpagoside Inhibits RANKL-Induced Osteoclastogenesis via Syk-Btk-PLCγ2-Ca2+ Signaling Pathway and Prevents Inflammation-Mediated Bone Loss

Published:2015-08-26 Issue:9 Volume:78 Page:2167-2174
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Kim Ju-Young¹,Park Sun-Hyang¹,Baek Jong Min¹,Erkhembaatar Munkhsoyol¹,Kim Min Seuk¹,Yoon Kwon-Ha¹,Oh Jaemin¹,Lee Myeung Su¹

Affiliation:

1. Imaging Science-Based Lung and Bone Diseases Research Center, ‡Department of Anatomy, School of Medicine, §Department of Oral Physiology, School of Dentistry, ⊥Department of Radiology, School of Medicine, ∥Institute for Skeletal Disease, and ▽Division of Rheumatology, Department of Internal Medicine, Wonkwang University, Iksan, Jeonbuk 570-749, Korea

Funder

Ministry of Health and Welfare

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.5b00233

Reference62 articles.

1. Public Health Impact of Osteoporosis

2. Causes of Age-Related Bone Loss and Bone Fragility: An Alternative View

3. Osteoporosis and risk of fracture, analysis on a population admitted in rehabilitation post-acute